🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Oral Dydrogesterone as Luteal Phase Support in Natural Cycle FET

RecruitingPhase 3Ages 18 Years - 42 YearsFemaleThe University of Hong Kong
NCT03859921 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This randomised double-blinded controlled trial aims to compare the live birth rate in natural FET cycles with and without oral dydrogesterone as luteal phase support. The hypothesis is that the use of oral dydrogesterone will increase the live birth rate of natural cycle FET.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age of women \<43 years at the time of stimulated IVF * Replacing early cleavage embryos or blastocysts after thawing Exclusion Criteria: * Requiring hormonal replacement cycles * Use of donor oocytes or embryos * Undergoing preimplantation genetic testing * Presence of hydrosalpinx not corrected surgically prior to FET * Refusal to join the study
💊

What it tests

  • Dydrogesterone
  • Placebo
📍

Where

1 site
Department of Obstetrics and Gynaecology
Hong Kong, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy